Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy
| Author | Setareh Dashti Shokoohi | en |
| Author | Mehdi Sheikhi | en |
| Author | Pouya Safarzadeh Kozani | en |
| Author | Pooria Safarzadeh Kozani | en |
| Author | Mehdi Rabiee Valashedi | en |
| Author | Chia Bamshad | en |
| Author | Amirsadegh Nikoo | en |
| Author | Abdolkarim Sheikhi | en |
| Orcid | Pouya Safarzadeh Kozani [0000-0002-2602-3871] | en |
| Orcid | Pooria Safarzadeh Kozani [0000-0002-9901-7851] | en |
| Orcid | Abdolkarim Sheikhi [0000-0002-3559-5548] | en |
| Issued Date | 2023-02-28 | en |
| Abstract | This article does not have an abstract. | en |
| DOI | https://doi.org/10.5812/tms-131916 | en |
| Keyword | CAR-T Cell | en |
| Keyword | Cancer | en |
| Keyword | Immunotherapy | en |
| Publisher | Brieflands | en |
| Title | Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy | en |
| Type | Letter | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- tms-3-1-131916.pdf
- Size:
- 83.75 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF